Therapeutic compositions for reducing sebum secretion
AssigneeHoffmann-La Roche Inc.
InventorAlfred Boris
Life of this patent
Estimating the term…
Abstract
This invention is directed to methods for and compositions useful in reducing sebum secretion utilizing 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-[.alpha.-methylstyryl]naphthalene as an active ingredient.
Claims26
A method for reducing sebum secretion which comprises the administration to patients of a composition containing a present in an amount effective for reducing sebum secretion, said compound being represented by the following structural formula:
- ##STR2##
A method for combatting seborrhea which comprises the administration to patients an effective amount of a composition comprising a therapeutically inert pharmaceutically acceptable carrier and a compound represented by the following structural formula:
- ##STR3##
A method for the treatment of dandruff which comprises the administration to patients of an effective amount of a composition comprising a therapeutically inert pharmaceutically acceptable carrier and a compound represented by the following structural formula:
- ##STR4##
A method for combatting acne comprising administering to a patient a composition containing a pharmaceutically acceptable inert carrier and as an active ingredient the compound 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6[.alpha.-methylstyryl]naphthalene, said composition being administered in an amount effective to combat acne.
A composition in an oral unit dosage form comprising from about 0.05 to about 100 mg of 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl6-[.alpha.-methylstyryl]naphthalene and a therapeutically inert pharmaceutically acceptable carrier.
A composition for topical administration comprising a therapeutically inert pharmaceutically acceptable carrier and from about 0.0005 percent to about 10 percent of 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-[.alpha.-methylstyryl]naphthalene
Dependencies are inferred from the claim text.